| 5.4 |
21.5 |
GO:0032600 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 3.8 |
26.5 |
GO:0030421 |
defecation(GO:0030421) |
| 2.7 |
10.9 |
GO:2000754 |
regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 2.7 |
8.1 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 2.6 |
12.9 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 2.6 |
20.6 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 2.5 |
10.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 2.3 |
7.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 2.3 |
7.0 |
GO:0005999 |
xylulose biosynthetic process(GO:0005999) |
| 2.3 |
9.2 |
GO:0072302 |
negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 2.3 |
13.7 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 2.2 |
26.6 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 2.2 |
6.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 2.1 |
8.6 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 2.0 |
12.2 |
GO:0070378 |
positive regulation of ERK5 cascade(GO:0070378) |
| 2.0 |
32.2 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 2.0 |
8.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 2.0 |
5.9 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 1.8 |
10.7 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 1.8 |
14.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.8 |
1.8 |
GO:0072301 |
regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 1.7 |
5.2 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.7 |
1.7 |
GO:1900450 |
negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 1.7 |
5.1 |
GO:0046713 |
borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 1.7 |
6.6 |
GO:2000607 |
regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
| 1.6 |
4.9 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 1.6 |
9.7 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 1.6 |
6.5 |
GO:0016334 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 1.6 |
1.6 |
GO:0072166 |
posterior mesonephric tubule development(GO:0072166) |
| 1.6 |
11.1 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.6 |
4.7 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.6 |
3.1 |
GO:0072047 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 1.6 |
7.8 |
GO:0061441 |
renal artery morphogenesis(GO:0061441) |
| 1.6 |
9.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.6 |
4.7 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 1.5 |
7.7 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 1.5 |
6.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.5 |
6.0 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 1.5 |
7.4 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.5 |
5.8 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 1.5 |
5.8 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.5 |
7.3 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 1.4 |
2.8 |
GO:0060932 |
His-Purkinje system cell differentiation(GO:0060932) |
| 1.4 |
4.3 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 1.4 |
4.2 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 1.4 |
1.4 |
GO:0045643 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.4 |
5.6 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 1.4 |
4.2 |
GO:0042946 |
glucoside transport(GO:0042946) |
| 1.4 |
5.5 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 1.4 |
4.1 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.3 |
4.0 |
GO:0060957 |
endocardial cell fate commitment(GO:0060957) endocardial cushion cell differentiation(GO:0061443) endocardial cushion cell fate commitment(GO:0061445) |
| 1.3 |
1.3 |
GO:0016107 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.3 |
2.6 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.3 |
2.6 |
GO:0072249 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.3 |
3.9 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 1.3 |
3.8 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.3 |
7.6 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.3 |
8.8 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.3 |
5.0 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 1.3 |
7.5 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 1.2 |
3.7 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 1.2 |
6.2 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 1.2 |
1.2 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) |
| 1.2 |
6.2 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 1.2 |
3.7 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.2 |
9.8 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 1.2 |
7.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.2 |
16.9 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.2 |
3.6 |
GO:0060139 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.2 |
1.2 |
GO:0060769 |
positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
| 1.2 |
6.0 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 1.2 |
3.6 |
GO:0031104 |
dendrite regeneration(GO:0031104) |
| 1.2 |
1.2 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 1.2 |
4.8 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.2 |
3.6 |
GO:1904864 |
regulation of beta-catenin-TCF complex assembly(GO:1904863) negative regulation of beta-catenin-TCF complex assembly(GO:1904864) |
| 1.2 |
4.7 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 1.2 |
4.7 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.2 |
7.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.2 |
4.6 |
GO:0001868 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.2 |
4.6 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 1.2 |
10.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 1.2 |
3.5 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 1.1 |
2.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.1 |
4.6 |
GO:0046732 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.1 |
4.6 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 1.1 |
5.7 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 1.1 |
3.4 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 1.1 |
1.1 |
GO:2000224 |
regulation of testosterone biosynthetic process(GO:2000224) |
| 1.1 |
4.5 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 1.1 |
4.5 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 1.1 |
4.4 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 1.1 |
5.6 |
GO:1904747 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.1 |
8.9 |
GO:0071306 |
cellular response to vitamin E(GO:0071306) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.1 |
14.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 1.1 |
3.3 |
GO:2000798 |
amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 1.1 |
4.4 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 1.1 |
1.1 |
GO:2000850 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 1.1 |
5.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 1.1 |
3.2 |
GO:1900135 |
positive regulation of renin secretion into blood stream(GO:1900135) |
| 1.1 |
1.1 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.1 |
4.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 1.0 |
10.5 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 1.0 |
3.1 |
GO:0075509 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.0 |
3.1 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.0 |
3.1 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 1.0 |
8.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 1.0 |
7.2 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.0 |
4.1 |
GO:1903173 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.0 |
5.1 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 1.0 |
4.1 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.0 |
5.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.0 |
3.0 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 |
5.0 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.0 |
3.0 |
GO:1903414 |
spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 1.0 |
3.0 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.0 |
3.0 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.0 |
1.0 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 1.0 |
2.9 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 1.0 |
1.9 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 1.0 |
3.8 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 1.0 |
15.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.9 |
0.9 |
GO:0071288 |
cellular response to mercury ion(GO:0071288) |
| 0.9 |
26.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.9 |
2.8 |
GO:1902598 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.9 |
2.8 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.9 |
4.7 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.9 |
14.0 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.9 |
4.7 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 |
3.7 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.9 |
10.1 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.9 |
4.6 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.9 |
2.8 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.9 |
3.7 |
GO:0071684 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.9 |
0.9 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.9 |
3.7 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.9 |
5.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.9 |
2.7 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.9 |
4.5 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.9 |
1.8 |
GO:0071931 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 0.9 |
19.7 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.9 |
0.9 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.9 |
3.6 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.9 |
4.5 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.9 |
2.7 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.9 |
1.8 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.9 |
0.9 |
GO:0009912 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.9 |
3.5 |
GO:0072179 |
optic nerve formation(GO:0021634) regulation of metanephros size(GO:0035566) pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) optic chiasma development(GO:0061360) kidney rudiment formation(GO:0072003) kidney field specification(GO:0072004) nephric duct formation(GO:0072179) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
| 0.9 |
4.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.9 |
8.8 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.9 |
2.6 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.9 |
0.9 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.9 |
7.9 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.9 |
3.5 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.9 |
5.3 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.9 |
3.5 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.9 |
9.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.9 |
7.0 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.9 |
2.6 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.9 |
7.8 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.9 |
5.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.9 |
3.4 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.9 |
5.1 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.8 |
4.2 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.8 |
5.9 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.8 |
2.5 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.8 |
0.8 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.8 |
3.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 |
5.0 |
GO:0003183 |
mitral valve morphogenesis(GO:0003183) |
| 0.8 |
11.7 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.8 |
3.3 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.8 |
3.3 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.8 |
5.0 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 |
0.8 |
GO:0060458 |
right lung development(GO:0060458) |
| 0.8 |
2.5 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.8 |
8.2 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.8 |
3.3 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.8 |
3.2 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.8 |
4.1 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.8 |
1.6 |
GO:0005985 |
sucrose metabolic process(GO:0005985) |
| 0.8 |
4.8 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.8 |
11.2 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.8 |
3.2 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.8 |
4.0 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.8 |
3.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.8 |
2.4 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.8 |
4.8 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.8 |
2.4 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.8 |
2.4 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.8 |
0.8 |
GO:0019483 |
beta-alanine biosynthetic process(GO:0019483) |
| 0.8 |
4.7 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.8 |
1.6 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.8 |
0.8 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.8 |
3.9 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.8 |
3.1 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.8 |
5.4 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.8 |
1.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.8 |
1.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.8 |
1.5 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 |
2.3 |
GO:0006212 |
uracil catabolic process(GO:0006212) |
| 0.8 |
0.8 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.8 |
2.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.8 |
4.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.8 |
2.3 |
GO:0007225 |
patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.8 |
3.8 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.7 |
4.5 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.7 |
3.7 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.7 |
3.7 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
| 0.7 |
8.9 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.7 |
7.4 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.7 |
1.5 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.7 |
1.5 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.7 |
0.7 |
GO:0060876 |
semicircular canal formation(GO:0060876) |
| 0.7 |
2.9 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.7 |
2.2 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.7 |
2.2 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.7 |
1.5 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.7 |
5.1 |
GO:0044800 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.7 |
28.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.7 |
1.5 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.7 |
3.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.7 |
1.5 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.7 |
5.8 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.7 |
2.2 |
GO:2001035 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.7 |
2.2 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.7 |
6.5 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 |
2.1 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.7 |
2.9 |
GO:0052229 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.7 |
0.7 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.7 |
2.8 |
GO:0042223 |
positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.7 |
0.7 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.7 |
3.5 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.7 |
2.8 |
GO:0034635 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.7 |
2.1 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.7 |
6.3 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.7 |
2.1 |
GO:2000452 |
CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.7 |
4.9 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.7 |
2.1 |
GO:0015744 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.7 |
7.0 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.7 |
7.7 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.7 |
2.8 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.7 |
1.4 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.7 |
4.2 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.7 |
6.2 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.7 |
11.8 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 0.7 |
2.8 |
GO:1903182 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.7 |
3.5 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.7 |
0.7 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.7 |
8.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.7 |
17.9 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.7 |
1.4 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.7 |
2.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.7 |
4.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.7 |
8.2 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.7 |
7.5 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.7 |
3.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.7 |
4.8 |
GO:0043387 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.7 |
1.4 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.7 |
4.1 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.7 |
3.4 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 |
3.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 |
1.4 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.7 |
4.1 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.7 |
2.0 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.7 |
4.1 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.7 |
2.0 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.7 |
8.1 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.7 |
1.3 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.7 |
3.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.7 |
2.0 |
GO:0035732 |
nitric oxide storage(GO:0035732) |
| 0.7 |
6.0 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.7 |
3.3 |
GO:0060319 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) primitive erythrocyte differentiation(GO:0060319) |
| 0.7 |
4.0 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 |
5.3 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.7 |
7.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.7 |
10.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.7 |
2.7 |
GO:1905229 |
cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.7 |
2.0 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.7 |
5.3 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.7 |
0.7 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.7 |
5.3 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.7 |
4.0 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.7 |
1.3 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.7 |
2.6 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.7 |
2.0 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.7 |
2.0 |
GO:1902905 |
positive regulation of fibril organization(GO:1902905) |
| 0.7 |
1.3 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.7 |
3.9 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.7 |
3.3 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.7 |
3.3 |
GO:0097403 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.7 |
3.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.7 |
0.7 |
GO:1904582 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.7 |
1.3 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.6 |
2.6 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.6 |
3.9 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.6 |
1.9 |
GO:0002906 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.6 |
0.6 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.6 |
0.6 |
GO:0036510 |
trimming of terminal mannose on C branch(GO:0036510) |
| 0.6 |
3.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.6 |
3.2 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.6 |
1.9 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.6 |
1.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.6 |
0.6 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.6 |
10.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.6 |
3.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.6 |
6.9 |
GO:0072505 |
phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.6 |
3.8 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.6 |
0.6 |
GO:0060995 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.6 |
3.1 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.6 |
3.1 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.6 |
13.8 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.6 |
2.5 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.6 |
17.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.6 |
3.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 |
2.5 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.6 |
1.2 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.6 |
0.6 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 0.6 |
3.1 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 |
1.9 |
GO:0090210 |
regulation of establishment of blood-brain barrier(GO:0090210) |
| 0.6 |
12.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.6 |
0.6 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.6 |
1.8 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.6 |
0.6 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.6 |
1.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.6 |
3.6 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.6 |
0.6 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.6 |
5.4 |
GO:0071910 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.6 |
7.8 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.6 |
5.4 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.6 |
0.6 |
GO:0001796 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.6 |
0.6 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.6 |
6.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.6 |
1.2 |
GO:0032803 |
regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.6 |
4.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.6 |
8.3 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.6 |
2.4 |
GO:2000434 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.6 |
1.8 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.6 |
0.6 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.6 |
1.8 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) |
| 0.6 |
2.4 |
GO:0035283 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.6 |
1.8 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.6 |
2.4 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.6 |
1.8 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.6 |
0.6 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.6 |
2.3 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.6 |
1.2 |
GO:0071877 |
regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.6 |
0.6 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.6 |
2.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.6 |
1.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.6 |
1.7 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.6 |
1.7 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.6 |
6.9 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.6 |
5.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 |
0.6 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.6 |
0.6 |
GO:0060928 |
atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.6 |
13.2 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.6 |
1.7 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.6 |
1.7 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.6 |
1.7 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.6 |
0.6 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.6 |
2.3 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.6 |
1.7 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 0.6 |
1.1 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.6 |
0.6 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) |
| 0.6 |
0.6 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.6 |
1.7 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.6 |
0.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.6 |
2.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.6 |
2.8 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.6 |
0.6 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.6 |
2.2 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.6 |
3.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.6 |
1.1 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.6 |
0.6 |
GO:0003343 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.5 |
5.5 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.5 |
1.6 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.5 |
1.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.5 |
8.7 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.5 |
1.6 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.5 |
3.3 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.5 |
2.7 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.5 |
9.2 |
GO:0072338 |
cellular lactam metabolic process(GO:0072338) |
| 0.5 |
2.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.5 |
3.2 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.5 |
5.9 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.5 |
3.8 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.5 |
17.1 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.5 |
1.6 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.5 |
0.5 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 |
2.1 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.5 |
1.6 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 0.5 |
2.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 |
3.7 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.5 |
0.5 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.5 |
2.6 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.5 |
0.5 |
GO:1901674 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.5 |
5.2 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 |
7.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.5 |
1.6 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.5 |
4.2 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.5 |
9.8 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.5 |
2.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.5 |
1.5 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 |
1.5 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.5 |
4.1 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.5 |
6.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.5 |
1.5 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.5 |
3.6 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.5 |
3.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.5 |
5.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.5 |
8.1 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.5 |
1.5 |
GO:1903576 |
response to L-arginine(GO:1903576) |
| 0.5 |
9.1 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.5 |
3.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 |
0.5 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.5 |
1.5 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.5 |
2.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
4.0 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.5 |
3.0 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.5 |
4.0 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.5 |
2.0 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 |
2.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 |
2.0 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.5 |
2.5 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.5 |
5.9 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.5 |
2.0 |
GO:2000399 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.5 |
1.0 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.5 |
2.0 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.5 |
4.4 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.5 |
2.9 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.5 |
4.4 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 |
0.5 |
GO:0071899 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.5 |
9.7 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.5 |
0.5 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.5 |
1.0 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.5 |
1.0 |
GO:0060545 |
positive regulation of necroptotic process(GO:0060545) |
| 0.5 |
4.3 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.5 |
2.4 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.5 |
5.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.5 |
7.7 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 |
5.7 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.5 |
1.0 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.5 |
1.4 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.5 |
4.3 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.5 |
1.4 |
GO:0032352 |
positive regulation of hormone metabolic process(GO:0032352) |
| 0.5 |
2.4 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.5 |
1.0 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.5 |
1.0 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.5 |
3.3 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.5 |
2.4 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.5 |
3.3 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.5 |
1.4 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.5 |
2.8 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.5 |
1.9 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 |
2.8 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.5 |
2.8 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.5 |
2.3 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.5 |
2.3 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.5 |
7.9 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.5 |
3.3 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.5 |
1.4 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.5 |
1.4 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.5 |
1.9 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 |
1.4 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.5 |
1.4 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.5 |
2.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 |
2.3 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.5 |
2.3 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.5 |
1.4 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of phenotypic switching(GO:1900239) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.5 |
2.3 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 |
0.5 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.5 |
4.1 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.5 |
9.2 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.5 |
1.4 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.5 |
1.4 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.5 |
0.5 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.5 |
7.3 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 |
1.4 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.5 |
2.3 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.5 |
5.4 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.5 |
2.7 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.4 |
4.0 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 |
3.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 |
0.4 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.4 |
2.2 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.4 |
0.9 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.4 |
1.8 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.4 |
2.2 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.4 |
4.4 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.4 |
7.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 |
7.0 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.4 |
2.2 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.4 |
0.4 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
4.4 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.4 |
0.9 |
GO:0007350 |
blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.4 |
1.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.4 |
1.3 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.4 |
2.2 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.4 |
1.7 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.4 |
6.9 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 |
1.3 |
GO:2000439 |
positive regulation of monocyte extravasation(GO:2000439) |
| 0.4 |
1.7 |
GO:0035089 |
establishment of apical/basal cell polarity(GO:0035089) |
| 0.4 |
5.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.4 |
1.7 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.4 |
2.6 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.4 |
1.7 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.4 |
1.7 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.4 |
0.9 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 |
5.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.4 |
0.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.4 |
1.7 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.4 |
1.7 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 |
3.8 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.4 |
0.9 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.4 |
6.4 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.4 |
0.9 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.4 |
0.4 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.4 |
2.5 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.4 |
0.4 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.4 |
0.4 |
GO:0009155 |
purine deoxyribonucleotide catabolic process(GO:0009155) |
| 0.4 |
1.7 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.4 |
1.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
5.1 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.4 |
1.7 |
GO:0070781 |
protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.4 |
0.8 |
GO:0045355 |
negative regulation of interferon-alpha biosynthetic process(GO:0045355) |
| 0.4 |
0.8 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.4 |
1.2 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.4 |
2.1 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.4 |
1.7 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.4 |
1.7 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 |
0.4 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.4 |
1.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 |
2.9 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) |
| 0.4 |
1.7 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.4 |
7.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 |
0.8 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.4 |
2.9 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.4 |
1.6 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.4 |
1.2 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.4 |
1.2 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.4 |
4.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.4 |
1.2 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 |
7.3 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.4 |
2.0 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.4 |
4.9 |
GO:0009415 |
response to water(GO:0009415) |
| 0.4 |
2.0 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
1.6 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
5.7 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.4 |
0.8 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.4 |
1.2 |
GO:0008358 |
oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.4 |
6.1 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 |
2.0 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.4 |
2.4 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.4 |
1.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.4 |
6.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
2.0 |
GO:0002248 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 0.4 |
0.4 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.4 |
5.2 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.4 |
7.9 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.4 |
2.0 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.4 |
5.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.4 |
3.9 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 |
0.4 |
GO:0061438 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.4 |
0.8 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.4 |
1.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.4 |
6.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.4 |
1.2 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.4 |
3.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.4 |
1.9 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 |
9.7 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.4 |
5.8 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.4 |
1.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 |
0.8 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.4 |
1.2 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.4 |
1.2 |
GO:2001311 |
lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.4 |
1.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.4 |
3.5 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.4 |
1.5 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.4 |
1.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
2.7 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.4 |
0.4 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.4 |
0.8 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.4 |
7.2 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.4 |
4.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.4 |
6.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.4 |
0.4 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.4 |
1.9 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 |
1.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.4 |
4.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.4 |
0.4 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.4 |
0.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
2.3 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 |
1.1 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 |
5.6 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 |
3.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
2.6 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.4 |
1.1 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.4 |
2.6 |
GO:0090094 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.4 |
1.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.4 |
4.4 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.4 |
0.7 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.4 |
1.5 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.4 |
8.8 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 |
0.4 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.4 |
7.7 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.4 |
4.0 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
1.8 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.4 |
2.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 |
0.7 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.4 |
0.4 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
1.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.4 |
7.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.4 |
1.8 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.4 |
1.8 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.4 |
5.4 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.4 |
1.8 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.4 |
1.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 |
3.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.4 |
1.1 |
GO:0038158 |
granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.4 |
2.5 |
GO:0010816 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 |
16.0 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.4 |
1.8 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.4 |
0.7 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.4 |
0.7 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.4 |
0.4 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.4 |
1.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.4 |
5.3 |
GO:0060177 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.4 |
1.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
1.1 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.4 |
1.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 |
1.1 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.3 |
7.0 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
0.3 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 |
0.3 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.3 |
4.2 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.3 |
1.4 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
| 0.3 |
2.4 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 |
3.5 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.3 |
5.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
1.4 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.3 |
1.7 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 |
1.0 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 |
4.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.3 |
1.0 |
GO:0036255 |
response to methylamine(GO:0036255) response to lipoic acid(GO:1903442) |
| 0.3 |
2.0 |
GO:0061187 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.3 |
1.7 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.3 |
1.7 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.3 |
1.0 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.3 |
2.4 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.3 |
0.3 |
GO:0045077 |
negative regulation of interferon-gamma biosynthetic process(GO:0045077) negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
4.4 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.3 |
1.0 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 |
1.0 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 |
4.7 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 |
2.3 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.3 |
1.0 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.3 |
7.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 |
1.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.3 |
1.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 |
10.6 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.3 |
1.0 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.3 |
2.3 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 |
7.3 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 |
1.3 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.3 |
2.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
6.6 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.3 |
3.0 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.3 |
0.7 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.3 |
2.3 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.3 |
1.0 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.3 |
1.0 |
GO:0044848 |
biological phase(GO:0044848) |
| 0.3 |
1.0 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.3 |
1.0 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.3 |
4.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.3 |
12.1 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.3 |
3.6 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.3 |
1.0 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.3 |
0.3 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.3 |
1.9 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.3 |
7.7 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 |
1.0 |
GO:0048205 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 |
3.2 |
GO:0010755 |
regulation of plasminogen activation(GO:0010755) |
| 0.3 |
2.2 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.3 |
1.6 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
9.6 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.3 |
18.2 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.3 |
3.8 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.3 |
1.3 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.3 |
2.9 |
GO:0000730 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
1.9 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.3 |
0.3 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.3 |
0.9 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.3 |
0.6 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.3 |
2.8 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.3 |
0.9 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 |
3.1 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.3 |
8.1 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.3 |
0.9 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.3 |
1.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
2.5 |
GO:0048296 |
regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.3 |
1.6 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
0.9 |
GO:0015734 |
taurine transport(GO:0015734) |
| 0.3 |
0.6 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
1.9 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
3.7 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.3 |
0.6 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.3 |
1.2 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.3 |
3.7 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.3 |
2.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
3.1 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.3 |
0.3 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.3 |
0.9 |
GO:0043465 |
fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.3 |
1.5 |
GO:0002468 |
dendritic cell antigen processing and presentation(GO:0002468) |
| 0.3 |
9.8 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.3 |
2.8 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.3 |
3.4 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.3 |
4.3 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.3 |
4.3 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.3 |
0.9 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.3 |
1.5 |
GO:0006231 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.3 |
3.4 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.3 |
0.9 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.3 |
1.8 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 |
0.6 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.3 |
0.3 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 |
1.2 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.3 |
3.0 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.3 |
2.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
2.7 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
2.1 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.3 |
4.8 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.3 |
0.3 |
GO:1903015 |
regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.3 |
1.2 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.3 |
3.0 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.3 |
1.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
1.2 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.3 |
0.9 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
2.1 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.3 |
0.6 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.3 |
1.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.3 |
7.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 |
7.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.3 |
5.6 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.3 |
1.8 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.3 |
0.9 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.3 |
0.3 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.3 |
3.0 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.3 |
0.3 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.3 |
2.4 |
GO:1904994 |
regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
| 0.3 |
1.5 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.3 |
4.1 |
GO:0002070 |
epithelial cell maturation(GO:0002070) |
| 0.3 |
3.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.3 |
27.1 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.3 |
4.1 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) |
| 0.3 |
2.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
1.7 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 |
0.9 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.3 |
3.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
3.8 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.3 |
3.5 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.3 |
6.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
0.6 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.3 |
0.6 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.3 |
0.9 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 |
2.9 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.3 |
4.3 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
3.7 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.3 |
0.9 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.3 |
2.6 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 |
6.0 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.3 |
1.7 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.3 |
0.9 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) |
| 0.3 |
2.6 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.3 |
1.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.3 |
0.3 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.3 |
0.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) glucosamine catabolic process(GO:0006043) |
| 0.3 |
0.8 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 |
4.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.3 |
0.6 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.3 |
3.4 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 |
0.8 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 |
0.8 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.3 |
4.8 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.3 |
7.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.3 |
4.5 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.3 |
3.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 |
0.3 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.3 |
1.4 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.3 |
1.4 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.3 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
0.6 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.3 |
0.3 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.3 |
1.4 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 |
1.7 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
2.2 |
GO:0071636 |
positive regulation of transforming growth factor beta production(GO:0071636) |
| 0.3 |
2.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.3 |
2.2 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.3 |
1.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.3 |
1.1 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 0.3 |
1.1 |
GO:1903567 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.3 |
1.9 |
GO:0043316 |
cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.3 |
0.5 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
| 0.3 |
1.6 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.3 |
1.1 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
0.8 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 |
6.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.3 |
0.5 |
GO:0002190 |
cap-independent translational initiation(GO:0002190) |
| 0.3 |
1.4 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.3 |
0.8 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.3 |
0.5 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
1.1 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 |
2.7 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.3 |
2.1 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.3 |
0.3 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.3 |
7.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
1.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
0.3 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 |
0.5 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 0.3 |
7.4 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.3 |
0.3 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.3 |
0.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.3 |
2.4 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.3 |
0.3 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 |
1.8 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.3 |
0.3 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.3 |
0.3 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.3 |
0.3 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.3 |
0.3 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.3 |
1.3 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.3 |
1.3 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.3 |
0.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.3 |
1.3 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 |
0.5 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 |
3.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.3 |
1.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 |
7.6 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.3 |
2.0 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.3 |
0.8 |
GO:0070904 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 |
3.5 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.3 |
1.0 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.3 |
0.3 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 |
0.8 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.3 |
5.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 |
5.8 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 |
3.0 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.3 |
6.5 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.3 |
5.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
1.0 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
1.0 |
GO:0032431 |
activation of phospholipase A2 activity(GO:0032431) |
| 0.2 |
0.2 |
GO:0051801 |
cytolysis by symbiont of host cells(GO:0001897) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
| 0.2 |
3.5 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
1.5 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
1.7 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 |
0.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
4.5 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.2 |
1.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
2.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
2.2 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
1.0 |
GO:0035549 |
detection of virus(GO:0009597) interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.2 |
0.7 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
0.7 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
3.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
0.5 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.2 |
1.9 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
1.2 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
6.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
3.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
1.0 |
GO:0045953 |
negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.2 |
0.2 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.2 |
1.4 |
GO:0097205 |
renal filtration(GO:0097205) |
| 0.2 |
0.5 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.2 |
2.4 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.2 |
4.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
0.7 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
0.2 |
GO:2000389 |
regulation of neutrophil extravasation(GO:2000389) |
| 0.2 |
1.0 |
GO:0070476 |
RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.2 |
1.4 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 |
4.3 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
0.7 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 |
0.9 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.2 |
0.7 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 |
4.5 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 |
2.8 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.2 |
0.9 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.5 |
GO:0097676 |
histone H3-K36 trimethylation(GO:0097198) histone H3-K36 dimethylation(GO:0097676) |
| 0.2 |
0.5 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.2 |
0.5 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.2 |
1.2 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
2.6 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.2 |
3.0 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 |
0.7 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 |
3.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 |
2.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
0.2 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 |
3.7 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 |
17.0 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.2 |
1.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
0.2 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 |
1.1 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.2 |
7.1 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.2 |
1.1 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.2 |
1.1 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 |
2.3 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 |
2.9 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.2 |
0.5 |
GO:0048546 |
digestive tract morphogenesis(GO:0048546) |
| 0.2 |
2.9 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
2.5 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 |
5.6 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
1.8 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.2 |
0.7 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
2.7 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
1.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 |
0.4 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.7 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.2 |
0.2 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.2 |
5.5 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.2 |
1.1 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 |
1.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
0.7 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.2 |
0.2 |
GO:0061525 |
hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
| 0.2 |
2.8 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 |
0.2 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.2 |
0.2 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
0.2 |
GO:1901533 |
negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
| 0.2 |
0.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.2 |
2.8 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 |
1.1 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.2 |
0.2 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.2 |
1.1 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
| 0.2 |
31.5 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 |
0.9 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 |
0.4 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 0.2 |
0.8 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.2 |
4.7 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
3.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
1.5 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
1.1 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.2 |
0.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.2 |
10.3 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.2 |
2.9 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.2 |
0.4 |
GO:0097065 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
1.3 |
GO:0030890 |
positive regulation of B cell proliferation(GO:0030890) |
| 0.2 |
0.6 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.2 |
0.4 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.2 |
1.9 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
1.0 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 |
3.3 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.2 |
1.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.2 |
2.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 |
0.2 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.2 |
1.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
3.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
0.4 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.2 |
0.6 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
2.5 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.2 |
1.2 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.2 |
1.4 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.2 |
1.2 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.2 |
0.8 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.2 |
3.2 |
GO:0021840 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
| 0.2 |
2.4 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.2 |
10.7 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.2 |
1.6 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.6 |
GO:0006463 |
steroid hormone receptor complex assembly(GO:0006463) |
| 0.2 |
1.0 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.2 |
0.2 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.2 |
0.8 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
2.2 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.4 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
0.6 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.2 |
5.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
1.8 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.2 |
3.2 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.2 |
5.8 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.2 |
0.6 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
0.6 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 |
0.4 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.2 |
3.9 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.2 |
0.4 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.2 |
0.6 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.2 |
0.4 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.2 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.2 |
0.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 |
0.6 |
GO:1903259 |
exon-exon junction complex disassembly(GO:1903259) |
| 0.2 |
1.7 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.2 |
1.2 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
1.0 |
GO:2000329 |
peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.2 |
0.6 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.2 |
0.2 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.2 |
7.3 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.2 |
4.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
1.0 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 |
1.7 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.2 |
0.8 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.2 |
1.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
0.4 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
0.6 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.2 |
1.3 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
5.3 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.2 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
2.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.2 |
0.2 |
GO:0072710 |
response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.2 |
3.9 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.2 |
0.7 |
GO:0070640 |
vitamin D3 metabolic process(GO:0070640) |
| 0.2 |
0.4 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.2 |
3.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.2 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
4.5 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.2 |
0.4 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 |
1.3 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 |
0.2 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.2 |
8.1 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 |
0.6 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 |
0.6 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.2 |
0.6 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.2 |
0.9 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.2 |
2.0 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
6.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
1.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
2.8 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
1.1 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.2 |
5.3 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.2 |
0.5 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
2.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
1.4 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.2 |
0.2 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.2 |
0.5 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.2 |
0.5 |
GO:0036245 |
cellular response to menadione(GO:0036245) |
| 0.2 |
0.9 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.2 |
1.3 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 |
0.2 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.2 |
0.7 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
2.3 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.2 |
3.9 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.2 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
0.2 |
GO:0046882 |
negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.2 |
4.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 |
0.4 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.2 |
0.2 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.2 |
0.5 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
0.9 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 |
1.6 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.2 |
0.4 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 |
8.3 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
1.1 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.2 |
2.3 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
9.5 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.2 |
1.2 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.2 |
0.3 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 |
0.9 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
2.4 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.2 |
3.3 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.2 |
0.7 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.2 |
1.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.2 |
0.3 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
0.9 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.2 |
0.7 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.2 |
3.6 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
8.8 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.2 |
16.9 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 |
0.5 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
1.0 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.2 |
0.5 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.2 |
0.2 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 |
2.1 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.2 |
0.2 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.2 |
3.2 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
1.4 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.2 |
0.7 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.2 |
0.5 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
| 0.2 |
8.8 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.2 |
0.3 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 |
4.4 |
GO:0032481 |
positive regulation of type I interferon production(GO:0032481) |
| 0.2 |
4.0 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
3.7 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.2 |
3.4 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
0.7 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 |
2.7 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.2 |
11.3 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.2 |
5.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
1.7 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.2 |
0.7 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.2 |
1.3 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.2 |
0.5 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.2 |
0.7 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.2 |
0.7 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.2 |
0.5 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
2.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.2 |
3.6 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.2 |
0.2 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.2 |
1.6 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.2 |
1.3 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.2 |
0.7 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.2 |
2.0 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.2 |
1.5 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.2 |
0.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
0.3 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.2 |
0.5 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.2 |
1.8 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
0.8 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.2 |
0.6 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
6.0 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
1.8 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.2 |
0.8 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.2 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.2 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.2 |
0.6 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.2 |
3.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
1.1 |
GO:0070236 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
0.3 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 |
1.3 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.2 |
7.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
0.5 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.2 |
0.8 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.2 |
2.4 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.2 |
0.3 |
GO:0031393 |
negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.2 |
1.7 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.2 |
4.6 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.2 |
1.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
2.4 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 |
5.0 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.2 |
0.9 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 |
0.2 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 |
0.5 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.2 |
3.3 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 |
0.8 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.2 |
10.2 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 |
0.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.2 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.2 |
0.5 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
1.4 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.2 |
5.3 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.2 |
2.6 |
GO:2000647 |
negative regulation of stem cell proliferation(GO:2000647) |
| 0.2 |
16.9 |
GO:0030449 |
regulation of complement activation(GO:0030449) |
| 0.2 |
13.6 |
GO:0007588 |
excretion(GO:0007588) |
| 0.2 |
0.3 |
GO:0009631 |
cold acclimation(GO:0009631) |
| 0.2 |
0.5 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 |
0.5 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
1.8 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
1.5 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.3 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
1.6 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
1.5 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.6 |
GO:0036079 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
3.5 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.1 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.1 |
0.9 |
GO:0048145 |
regulation of fibroblast proliferation(GO:0048145) |
| 0.1 |
0.6 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
1.0 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) |
| 0.1 |
0.9 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.7 |
GO:0070922 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 0.1 |
2.8 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
2.3 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
7.4 |
GO:0006458 |
'de novo' protein folding(GO:0006458) |
| 0.1 |
1.6 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
1.0 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.1 |
1.0 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
1.1 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.1 |
1.0 |
GO:0071027 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
2.0 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
16.7 |
GO:0070268 |
cornification(GO:0070268) |
| 0.1 |
3.7 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
3.0 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.1 |
0.9 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.4 |
GO:0044598 |
polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.4 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.1 |
0.6 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.1 |
GO:0071231 |
cellular response to folic acid(GO:0071231) |
| 0.1 |
0.6 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
1.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.6 |
GO:1904045 |
cellular response to aldosterone(GO:1904045) |
| 0.1 |
0.8 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 |
3.2 |
GO:0090175 |
regulation of establishment of planar polarity(GO:0090175) |
| 0.1 |
0.8 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
12.7 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
1.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.1 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.1 |
0.3 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.1 |
0.1 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
0.4 |
GO:1903936 |
cellular response to sodium arsenite(GO:1903936) |
| 0.1 |
0.4 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.5 |
GO:0015801 |
aromatic amino acid transport(GO:0015801) |
| 0.1 |
0.4 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
8.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.3 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
1.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
1.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
2.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.7 |
GO:0052205 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
1.8 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.1 |
GO:0090133 |
mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.1 |
2.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
3.1 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
0.7 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
0.9 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.9 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.1 |
0.8 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 |
0.1 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) |
| 0.1 |
4.6 |
GO:0045682 |
regulation of epidermis development(GO:0045682) |
| 0.1 |
0.9 |
GO:0002353 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 |
0.5 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
5.1 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 |
3.0 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.1 |
0.9 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
0.4 |
GO:0039519 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) modulation by virus of host autophagy(GO:0039519) suppression by virus of host autophagy(GO:0039521) single-organism membrane invagination(GO:1902534) |
| 0.1 |
2.6 |
GO:1901890 |
positive regulation of cell junction assembly(GO:1901890) |
| 0.1 |
0.9 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
2.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 |
0.1 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.1 |
1.9 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
1.0 |
GO:0045191 |
regulation of isotype switching(GO:0045191) |
| 0.1 |
9.0 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
2.4 |
GO:0033627 |
cell adhesion mediated by integrin(GO:0033627) |
| 0.1 |
2.0 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.1 |
1.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.2 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.6 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.4 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) |
| 0.1 |
0.1 |
GO:0010182 |
hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
1.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.6 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.1 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.7 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
0.2 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.4 |
GO:0039689 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
4.8 |
GO:0000724 |
double-strand break repair via homologous recombination(GO:0000724) |
| 0.1 |
0.5 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.7 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.1 |
0.2 |
GO:0015847 |
putrescine transport(GO:0015847) |
| 0.1 |
3.9 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.5 |
GO:0006238 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
0.5 |
GO:0006393 |
termination of mitochondrial transcription(GO:0006393) |
| 0.1 |
0.2 |
GO:1903412 |
response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
| 0.1 |
5.0 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.1 |
7.8 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.1 |
0.2 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.6 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.1 |
1.5 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.1 |
1.2 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 |
0.6 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
0.9 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.6 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
3.2 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 |
0.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
1.8 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.3 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.3 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.6 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
1.2 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
0.2 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
51.0 |
GO:0048232 |
male gamete generation(GO:0048232) |
| 0.1 |
1.2 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.1 |
5.6 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.1 |
0.2 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
2.0 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.1 |
2.3 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
1.8 |
GO:0006306 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 |
0.1 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
0.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.8 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.6 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 |
0.2 |
GO:0032802 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 |
0.5 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.8 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
1.1 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.1 |
0.7 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.2 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.1 |
1.3 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.3 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 |
0.7 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.5 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.2 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.1 |
0.2 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
6.0 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.1 |
1.3 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.6 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.9 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.1 |
0.1 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.5 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.3 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
7.3 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 |
0.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.1 |
0.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
2.2 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.2 |
GO:0009886 |
post-embryonic morphogenesis(GO:0009886) |
| 0.1 |
0.3 |
GO:0071514 |
genetic imprinting(GO:0071514) |
| 0.1 |
0.6 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
2.5 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
1.9 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.5 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.1 |
3.1 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
1.8 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.6 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 |
0.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.3 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.5 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 |
1.0 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.5 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.1 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
1.6 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.2 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.4 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.1 |
0.7 |
GO:0032309 |
icosanoid secretion(GO:0032309) |
| 0.1 |
0.2 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.1 |
1.2 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.1 |
0.4 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 |
0.6 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.1 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.3 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 |
0.5 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.1 |
0.3 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
0.8 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.6 |
GO:1903376 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
1.6 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.6 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.1 |
0.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
1.9 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.5 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.5 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.1 |
1.2 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 |
0.3 |
GO:0033082 |
regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 |
0.2 |
GO:0034661 |
rRNA catabolic process(GO:0016075) ncRNA catabolic process(GO:0034661) |
| 0.1 |
3.7 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
1.5 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.2 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.1 |
0.3 |
GO:0000451 |
rRNA 2'-O-methylation(GO:0000451) |
| 0.1 |
0.5 |
GO:0060413 |
atrial septum morphogenesis(GO:0060413) |
| 0.1 |
1.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.4 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
9.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.3 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
0.4 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.1 |
3.3 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
1.1 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.1 |
2.0 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.4 |
GO:0038065 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
5.5 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.1 |
0.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
1.2 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 |
1.8 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
1.9 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.5 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
2.1 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.2 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.3 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.2 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
1.9 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
2.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 |
2.4 |
GO:0031100 |
organ regeneration(GO:0031100) |
| 0.1 |
0.4 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
1.8 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
0.5 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
0.2 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.1 |
0.4 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.3 |
GO:0071317 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.6 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.6 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.1 |
0.4 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.4 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.3 |
GO:0007549 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
1.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.7 |
GO:0010596 |
negative regulation of endothelial cell migration(GO:0010596) |
| 0.1 |
0.8 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.5 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.1 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
1.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
1.8 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.2 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) |
| 0.1 |
1.3 |
GO:0032652 |
regulation of interleukin-1 production(GO:0032652) |
| 0.1 |
1.4 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.1 |
4.0 |
GO:0001909 |
leukocyte mediated cytotoxicity(GO:0001909) |
| 0.1 |
4.7 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
1.2 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
1.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.3 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 |
0.4 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 |
0.7 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
0.8 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.1 |
0.9 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
1.3 |
GO:0007094 |
mitotic spindle assembly checkpoint(GO:0007094) |
| 0.1 |
0.1 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.8 |
GO:0030888 |
regulation of B cell proliferation(GO:0030888) |
| 0.1 |
0.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
2.8 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.2 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 |
0.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
0.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.1 |
GO:0070228 |
regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.1 |
1.0 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.1 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.1 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
4.7 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.4 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
4.2 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.1 |
1.7 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.1 |
0.5 |
GO:1902893 |
regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
| 0.1 |
0.2 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.5 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.3 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
0.2 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.1 |
GO:0032258 |
CVT pathway(GO:0032258) |
| 0.1 |
0.9 |
GO:0034694 |
response to prostaglandin(GO:0034694) |
| 0.1 |
0.5 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.2 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
0.1 |
GO:0071922 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.4 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
0.2 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.7 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.4 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.1 |
0.2 |
GO:1904894 |
positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.6 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 |
0.2 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.1 |
2.3 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
0.1 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.1 |
0.1 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.1 |
0.1 |
GO:0070541 |
response to platinum ion(GO:0070541) |
| 0.1 |
0.6 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.1 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.5 |
GO:0070232 |
regulation of T cell apoptotic process(GO:0070232) |
| 0.1 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.2 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.4 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.1 |
0.4 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.3 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
1.0 |
GO:0002260 |
lymphocyte homeostasis(GO:0002260) |
| 0.1 |
0.4 |
GO:0045842 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
2.5 |
GO:1990748 |
cellular detoxification(GO:1990748) |
| 0.1 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.6 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
1.0 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.6 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.1 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 |
1.4 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.4 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
2.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.1 |
GO:2000403 |
positive regulation of lymphocyte migration(GO:2000403) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.5 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.2 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.2 |
GO:0045900 |
cytoplasmic translational elongation(GO:0002182) negative regulation of translational elongation(GO:0045900) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.3 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.0 |
0.1 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.4 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 |
0.7 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 |
0.0 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.1 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.0 |
0.7 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.0 |
0.2 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 |
1.4 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.0 |
0.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.0 |
0.2 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.8 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.0 |
2.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.3 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
1.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
1.1 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
1.6 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.0 |
0.0 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.0 |
0.2 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.1 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
0.1 |
GO:0070145 |
mitochondrial asparaginyl-tRNA aminoacylation(GO:0070145) |
| 0.0 |
4.2 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.0 |
0.1 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
2.1 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 |
0.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.0 |
0.1 |
GO:0032196 |
transposition(GO:0032196) |
| 0.0 |
0.1 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 |
0.1 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.1 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.2 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.0 |
0.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.4 |
GO:2000142 |
regulation of DNA-templated transcription, initiation(GO:2000142) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.1 |
GO:0060571 |
morphogenesis of an epithelial fold(GO:0060571) |
| 0.0 |
0.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.0 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.0 |
0.1 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 |
0.1 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.4 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.1 |
GO:2000644 |
regulation of receptor catabolic process(GO:2000644) |
| 0.0 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.1 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.0 |
0.0 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.0 |
0.1 |
GO:0033216 |
ferric iron import(GO:0033216) |
| 0.0 |
0.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.4 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.2 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
1.6 |
GO:0001649 |
osteoblast differentiation(GO:0001649) |
| 0.0 |
0.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.1 |
GO:0061582 |
intestinal epithelial cell migration(GO:0061582) |
| 0.0 |
0.0 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.0 |
0.1 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.0 |
0.4 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.1 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 |
0.3 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 |
0.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.1 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.0 |
0.3 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.3 |
GO:0098727 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.0 |
1.0 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.1 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.0 |
0.3 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.2 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.1 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.0 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.0 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 |
0.4 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
